Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
MBIO
MBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest MBIO ETF News Today | Earnings, Events & Price Alerts
MBIO News
Ford Unveils 2027 Bronco RTR SUV, Priced Between $51,475 and $80,000
Jan 14 2026
CNBC
Ford Expands Bronco Lineup with New RTR Model Positioned Between $51,475 and $80,000
Jan 14 2026
Newsfilter
Cascade Prodrug Inc. Names Industry Experts Manuel (Manny) Litchman and Andres Gutierrez to Its Board of Directors
Aug 28 2025
Yahoo Finance
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
Jul 09 2025
Benzinga
3 Penny Stocks to Watch Now, 7/8/25
Jul 08 2025
TipRanks
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Jul 08 2025
Globenewswire
Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation
Jul 07 2025
Benzinga
Dow Dips 1%; Mustang Bio Shares Spike Higher
Jul 07 2025
Benzinga
Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS
Jul 07 2025
Benzinga
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Jul 07 2025
Newsfilter
Mustang Bio rises after FDA orphan drug status for MB-101
Jul 07 2025
SeekingAlpha
US Stocks Mixed; UniFirst Shares Fall After Q3 Results
Jul 02 2025
Benzinga
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Jul 02 2025
Benzinga
Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Jun 05 2025
Benzinga
Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Apr 24 2025
Benzinga
Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements
Mar 04 2025
NASDAQ.COM
Show More News
